NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

H. Lundbeck A/S (CO: LUN)

 
LUN Technical Analysis
5
As on 9th Jun 2022 LUN STOCK Price closed @ 172.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 200.75 & Strong Sell for SHORT-TERM with Stoploss of 228.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LUNSTOCK Price

Open 171.10 Change Price %
High 174.95 1 Day 1.60 0.94
Low 170.85 1 Week 8.00 4.86
Close 172.70 1 Month 9.85 6.05
Volume 368495 1 Year -38.60 -18.27
52 Week High 258.10 | 52 Week Low 147.10
 
CO Denmark Most Active Stocks
SAS 0.01 %
SAS-DKK 0.02 %
NOVO-B 867.10 %
VWS 186.20 %
ALMB 13.01 %
BIF 0.72 %
BIOPOR 1.36 %
DANSKE 207.30 %
TRYG 144.20 %
AMBU-B 111.35 %
 
CO Denmark Top Gainers Stocks
DKIEEU 249.00 15.81%
SYILATKL 237.20 3.40%
CWIGAAKKKL 200.80 3.03%
CWIASKL 243.70 2.65%
JYIKIKL 82.00 2.50%
CWIGAEKL 152.45 2.45%
CWIGAKL 1010.60 2.37%
AOJ-P 88.00 2.33%
CWISAKTKL 177.60 1.92%
NZYM-B 323.50 1.67%
 
CO Denmark Top Losers Stocks
BLVIS-A 0.40 -18.37%
VIPRO 0.88 -4.35%
SEIJHP 103.85 -3.53%
LSIDKA 121.13 -3.29%
SYVAAA 147.59 -2.68%
AUDNTS 5.50 -2.48%
HAINOR 106.06 -2.16%
SYVVUA 100.70 -2.14%
SYIVLVADKKA 162.76 -2.10%
SEIBVP 195.40 -2.03%
 
 
LUN
Daily Charts
LUN
Intraday Charts
Whats New @
Bazaartrend
LUN
Free Analysis
 
LUN Important Levels Intraday
RESISTANCE180.60
RESISTANCE178.07
RESISTANCE176.50
RESISTANCE174.93
SUPPORT170.47
SUPPORT168.90
SUPPORT167.33
SUPPORT164.80
 
LUN Forecast June 2024
4th UP Forecast282.73
3rd UP Forecast247.44
2nd UP Forecast225.63
1st UP Forecast203.82
1st DOWN Forecast141.58
2nd DOWN Forecast119.77
3rd DOWN Forecast97.96
4th DOWN Forecast62.67
 
LUN Weekly Forecast
4th UP Forecast199.49
3rd UP Forecast190.90
2nd UP Forecast185.59
1st UP Forecast180.28
1st DOWN Forecast165.12
2nd DOWN Forecast159.81
3rd DOWN Forecast154.50
4th DOWN Forecast145.91
 
LUN Forecast2024
4th UP Forecast399.7
3rd UP Forecast326.9
2nd UP Forecast281.9
1st UP Forecast236.9
1st DOWN Forecast108.5
2nd DOWN Forecast63.5
3rd DOWN Forecast18.5
4th DOWN Forecast-54.3
 
 
LUN Other Details
Segment EQ
Market Capital 35109937152.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
LUN Address
LUN
 
LUN Latest News
 
Your Comments and Response on H. Lundbeck A/S
 
LUN Business Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark. Address: Ottiliavej 9, Valby, Denmark, 2500
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service